15th Feb 2008 07:01
Consort Medical PLC15 February 2008 Consort Medical plc Consort Medical and Nektar Terminate Agreement Consort Medical (LSE: CSRT), formerly Bespak plc, a leader in medical devicesfor inhaled drug delivery and anaesthesia, today announces the termination ofits Exubera(R) inhaler manufacturing and supply agreement with NetkarTherapeutics. With this termination, Nektar will pay Consort Medical £11m forreimbursement of costs and expenses required to be paid by Nektar under theterms of the original agreement. This payment represents a significant proportion of the costs associated withthe restructuring programme undertaken by Consort Medical following thewithdrawal of Exubera(R). ENDS For further information, please contact: Consort Medical plcJonathan Glenn, Chief Executive Tel: +44 (0) 1908 552600Paul Broughton, Interim Group Finance Director MaitlandLiz Morley or Brian Hudspith Tel: +44 (0) 20 7379 5151 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
CSRT.L